Pacific Biosciences of California, Inc. (PACB)
NASDAQ: PACB · Real-Time Price · USD
2.390
-0.130 (-5.16%)
At close: Dec 5, 2025, 4:00 PM EST
2.370
-0.020 (-0.84%)
After-hours: Dec 5, 2025, 7:43 PM EST
PACB Stock Forecast
Stock Price Forecast
The 6 analysts with 12-month price forecasts for PACB stock have an average target of 2.00, with a low estimate of 1.50 and a high estimate of 3.00. The average target predicts a decrease of -16.32% from the current stock price of 2.39.
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for PACB stock from 6 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Jul '25 | Aug '25 | Sep '25 | Oct '25 | Nov '25 | Dec '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Buy | 3 | 2 | 2 | 2 | 2 | 2 |
| Hold | 5 | 5 | 5 | 5 | 4 | 3 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 9 | 8 | 8 | 8 | 7 | 6 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Piper Sandler | Piper Sandler | Hold Maintains $1.5 → $2 | Hold | Maintains | $1.5 → $2 | -16.32% | Nov 11, 2025 |
| Stephens & Co. | Stephens & Co. | Buy Maintains $1.8 → $2 | Buy | Maintains | $1.8 → $2 | -16.32% | Nov 10, 2025 |
| Piper Sandler | Piper Sandler | Hold Maintains $1.25 → $1.5 | Hold | Maintains | $1.25 → $1.5 | -37.24% | Aug 11, 2025 |
| Barclays | Barclays | Hold Maintains $2 → $1.5 | Hold | Maintains | $2 → $1.5 | -37.24% | Jun 25, 2025 |
| Piper Sandler | Piper Sandler | Hold Maintains $2 → $1.25 | Hold | Maintains | $2 → $1.25 | -47.70% | May 15, 2025 |
Financial Forecast
Revenue This Year
160.80M
from 154.01M
Increased by 4.41%
Revenue Next Year
179.71M
from 160.80M
Increased by 11.76%
EPS This Year
-1.67
from -1.13
EPS Next Year
-0.54
from -1.67
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | 170.1M | 193.8M | ||||
| Avg | 160.8M | 179.7M | ||||
| Low | 152.7M | 161.9M |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | 10.4% | 20.5% | ||||
| Avg | 4.4% | 11.8% | ||||
| Low | -0.9% | 0.7% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | -0.59 | -0.53 | ||||
| Avg | -1.67 | -0.54 | ||||
| Low | -1.85 | -0.56 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | - | - | ||||
| Avg | - | - | ||||
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.